Skip to main content
. 2022 Mar 1;12:782730. doi: 10.3389/fonc.2022.782730

Figure 3.

Figure 3

Kaplan–Meier analysis of patient significant factors in the multivariate analyses and outcomes of patients. PFS was analyzed according to the optimal CA19-9 response (A) and chemotherapy cycles (B). OS was analyzed according to the optimal CA19-9 response (C) and chemotherapy cycles (D). PFS, progression-free survival; OS, overall survival. Optimal CA19-9 response: Normalization and/or ≥50% decline compared with baseline.